CLINICAL_TRIALS
trial_result
· 2019-07-15
Clinical Trial Update: Glucophage Immediate Release (GIR) China Bioequivalence Study [Phase 1]
Summary
A Phase 1 bioequivalence study of Glucophage Immediate Release (GIR) conducted in China has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2019-07-15